Literature DB >> 25981383

Curcumin Reactivates Silenced Tumor Suppressor Gene RARβ by Reducing DNA Methylation.

Apei Jiang1,2, Xuemin Wang2, Xiaoyun Shan2, Yuan Li2, Pengqi Wang2, Pan Jiang2, Qing Feng2.   

Abstract

Reactivation of tumor suppressor genes by nontoxic bioactive food component represents a promising strategy for cancer chemoprevention. Retinoic acid receptor β (RARβ), one member of the RAR receptor family, is considered as a tumor suppressor. Reduced expression of RARβ has been reported in lung cancer and other solid tumors. DNA hypermethylation of the promoter region of RARβ is a major mechanism for its silencing in tumors. Recently, curcumin has been considered as a potential DNA methyltransferase inhibitor. Herein, we demonstrated that curcumin significantly elevate RARβ expression at the mRNA and protein levels in tested cancer cells. Additionally, curcumin decreased RARβ promoter methylation in lung cancer A549 and H460 cells. Mechanistic study demonstrated that curcumin was able to downregulate the mRNA levels of DNMT3b. In a lung cancer xenograft node mice model, curcumin exhibited protective effect against weight loss because of tumor burden. Tumor growth was strongly repressed by curcumin treatment. As the results from in vitro, RARβ mRNA were increased and DNMT3b mRNA were decreased by curcumin treatment compared with the mice in control group. Altogether, this study reveals a novel molecular mechanism of curcumin as a chemo-preventive agent for lung cancer through reactivation of RARβ.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  DNA methylation; RARβ; curcumin

Mesh:

Substances:

Year:  2015        PMID: 25981383     DOI: 10.1002/ptr.5373

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  22 in total

1.  DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice.

Authors:  Yue Guo; Renyi Wu; John M Gaspar; Davit Sargsyan; Zheng-Yuan Su; Chengyue Zhang; Linbo Gao; David Cheng; Wenji Li; Chao Wang; Ran Yin; Mingzhu Fang; Michael P Verzi; Ronald P Hart; Ah-Ng Kong
Journal:  Carcinogenesis       Date:  2018-05-03       Impact factor: 4.944

Review 2.  Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.

Authors:  Eswar Shankar; Rajnee Kanwal; Mario Candamo; Sanjay Gupta
Journal:  Semin Cancer Biol       Date:  2016-04-23       Impact factor: 15.707

Review 3.  Dietary antioxidants remodel DNA methylation patterns in chronic disease.

Authors:  Megan Beetch; Sadaf Harandi-Zadeh; Kate Shen; Katarzyna Lubecka; David D Kitts; Heather M O'Hagan; Barbara Stefanska
Journal:  Br J Pharmacol       Date:  2019-12-23       Impact factor: 8.739

Review 4.  Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy.

Authors:  Tianshu Yang; Yunkai Yang; Yan Wang
Journal:  Clin Epigenetics       Date:  2021-05-17       Impact factor: 6.551

Review 5.  The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions.

Authors:  Abdelhakim Bouyahya; Hamza Mechchate; Loubna Oumeslakht; Ikrame Zeouk; Sara Aboulaghras; Abdelaali Balahbib; Gokhan Zengin; Mohammad Amjad Kamal; Monica Gallo; Domenico Montesano; Nasreddine El Omari
Journal:  Biomolecules       Date:  2022-02-25

Review 6.  Clinicopathological significance and a potential drugtarget of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review.

Authors:  Xiaoyun Song; Kang Shi; Shi-Jie Zhou; Da-Ping Yu; Zhidong Liu; Yi Han
Journal:  Drug Des Devel Ther       Date:  2016-04-06       Impact factor: 4.162

7.  Curcumin increases exosomal TCF21 thus suppressing exosome-induced lung cancer.

Authors:  Hao Wu; Jingcheng Zhou; Chao Zeng; Da Wu; Zhimin Mu; Baokun Chen; Yuancai Xie; Yiwang Ye; Jixian Liu
Journal:  Oncotarget       Date:  2016-12-27

8.  Activation of the CRABPII/RAR pathway by curcumin induces retinoic acid mediated apoptosis in retinoic acid resistant breast cancer cells.

Authors:  Padmamalini Thulasiraman; Galen Garriga; Veena Danthuluri; Daniel J McAndrews; Imran Q Mohiuddin
Journal:  Oncol Rep       Date:  2017-03-08       Impact factor: 3.906

Review 9.  Association between Retinoic acid receptor-β hypermethylation and NSCLC risk: a meta-analysis and literature review.

Authors:  Yan Li; De-Guo Lu; Ying-Mei Ma; Hongxiang Liu
Journal:  Oncotarget       Date:  2017-01-24

Review 10.  Curcumin and colorectal cancer: An update and current perspective on this natural medicine.

Authors:  Wenhao Weng; Ajay Goel
Journal:  Semin Cancer Biol       Date:  2020-02-20       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.